RASGRP3 and thyroid gland carcinoma: Transfection of mutant RASGRP3 (RASGRP3-MUT) appeared to enhance the migratory and invasive abilities of thyroid cancer cells compared to transfection with wild-type RASGRP3 (RASGRP3-WT), accompanied by a decrease in iodine uptake capacity from 300×105 to 150×105.